Background—Heart failure (HF) is responsible for a huge burden in hospital care. Our goal
was to evaluate the value of N-terminal–pro-brain natriuretic peptide (NT-proBNP) in …

Objectives: The aim of this multicenter study was to evaluate the prognostic impact of a
therapeutic strategy using plasma brain natriuretic peptide (BNP) levels. Background: The …

Aims Heart failure (HF), a global pandemic affecting millions of individuals, calls for
adequate predictive guidance for improved therapy. Congestion, a key factor in HF‐related …

Neurohormonal activation is a commonly cited array of phenomena in the body's physiologic
response to heart failure. Although various neurohormones and pharmacologic agents that …

Aim To determine whether brain natriuretic peptide (BNP)‐guided heart failure (HF)
treatment improves morbidity and/or mortality when compared with conventional treatment …

Guidelines for the pharmacological treatment of heart failure (HF) are based on results from
large clinical trials demonstrating benefit. State of the art pharmacological management of …

OBJECTIVES:: To gain a better understanding of the scope and breadth of factors
associated with the B-type natriuretic peptides. DESIGN AND METHODS:: Databases were …

Aims Comparison of the value of echocardiography and B-type natriuretic peptide (BNP) in
monitoring response to treatment in patients admitted for acute heart failure (HF). Methods …

Objective—The purpose of this study was to investigate whether elevated asymmetrical
dimethylorginine (ADMA) concentrations are associated with increased cardiovascular risk …

OBJECTIVE: Elevated depressive symptoms have been linked to poorer prognosis in heart
failure (HF) patients. Our objective was to identify coping styles associated with depressive …